A new multisite study will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.

Travis Osterman, DO, MS, has been awarded a Microsoft Investigator Fellowship.

A five-year follow-up study of U.S. men who received prostate cancer treatment is creating a road map for future patients to clarify expectations and enable men to make informed choices about care.

Shari Barkin, MD, MSHS, division chief of General Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, was honored recently with the 2019 Academic Pediatric Association (APA) Research Award.

Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.

Vanderbilt University Medical Center has been awarded a two-year, $250,000 grant by The Robert Wood Johnson Foundation to develop new ways to measure trust in African-American men as it relates to health care.

Consuelo Wilkins, MD, MSCI, has been appointed director of a new Engagement Core to support the design, implementation and governance of the national All of Us Research Program, an ambitious effort led by the National Institutes of Health (NIH) to accelerate the prevention and treatment of illness through precision medicine.

Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation. Investigators, David Penson, M.D.